![Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study]()
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international studyStahl, Maximilian; Shallis, Rory M.; Wei, Wei; Montesinos, Pau; Lengline, Etienne; Neukirchen, Judith; Bhatt, Vijaya R.; Sekeres, Mikkael A.; Fathi, Amir T.; Konig, Heiko; Luger, Selina; Khan, Irum; Roboz, Gail J.; Cluzeau, Thomas; MartÃnez-Cuadron, David; Raffoux, Emmanuel; Germing, Ulrich; Umakanthan, Jayadev Manikkam; Mukherjee, Sudipto; Brunner, Andrew M.; Miller, Adam; McMahon, Christine M.; Ritchie, Ellen K.; RodrÃguez-Veiga, Rebeca; Itzykson, Raphaël; Boluda, Blanca; Rabian, Florence; Tormo, Mar; Acuña-Cruz, Evelyn; Rabinovich, Emma; Yoo, Brendan; Cano, Isabel; Podoltsev, Nikolai A.; Bewersdorf, Jan Philipp; Gore, Steven; Zeidan, Amer M. · Leukemia · 2020